☰

Yuanxiang Wang - Publications

Affiliations: 
Sun Yat-sen University, Guangzhou Shi, Guangdong Sheng, China 
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Frett B, McConnell N, Smith CC, Wang Y, Shah NP, Li HY. Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors. European Journal of Medicinal Chemistry. 94: 123-31. PMID 25765758 DOI: 10.1016/J.Ejmech.2015.02.052  0.615
2015 Wang Y, Frett B, McConnell N, Li HY. Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media. Organic & Biomolecular Chemistry. 13: 2958-64. PMID 25611884 DOI: 10.1039/c4ob02284j  0.563
2014 Frett B, McConnell N, Wang Y, Xu Z, Ambrose A, Li HY. Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studies. Medchemcomm. 5: 1507-1514. PMID 26843921 DOI: 10.1039/C4MD00251B  0.587
2014 Wang Y, Frett B, Li HY. Efficient access to 2,3-diarylimidazo[1,2-a]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation. Organic Letters. 16: 3016-9. PMID 24854606 DOI: 10.1021/ol501136e  0.57
2013 Frett B, Wang Y, Li HY. Targeting the K-Ras/PDEδ protein-protein interaction: the solution for Ras-driven cancers or just another therapeutic mirage? Chemmedchem. 8: 1620-2. PMID 23939923 DOI: 10.1002/cmdc.201300311  0.554
2013 Wang Y, Kaiser CE, Frett B, Li HY. Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators. Journal of Medicinal Chemistry. 56: 5219-30. PMID 23566315 DOI: 10.1021/jm3017706  0.582
Show low-probability matches.